Back
Emergent BioSolutions 10K Form
Sell
40
EBS
Emergent BioSolutions
Last Price:
9.14
Seasonality Move:
6.33%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-02 | 10Q | EBS/Emergent BioSolutions Quarterly |
| 2023-12-11 | 10Q | EBS/Emergent BioSolutions Quarterly |
| 2023-08-09 | 10Q | EBS/Emergent BioSolutions Quarterly |
| 2023-05-10 | 10Q | EBS/Emergent BioSolutions Quarterly |
| 2022-11-09 | 10Q | EBS/Emergent BioSolutions Quarterly |
| 2022-08-02 | 10Q | EBS/Emergent BioSolutions Quarterly |
Receive EBS News And Ratings
See the #1 stock for the next 7 days that we like better than EBS
EBS Financial Statistics
Sales & Book Value
| Annual Sales: | $1.02B |
|---|---|
| Cash Flow: | $42.9M |
| Price / Cash Flow: | 12.68 |
| Annual Sales: | $7.30 |
| Price / Book: | 1.25 |
Profitability
| EPS (TTM): | -11.24000 |
|---|---|
| Net Income (TTM): | $-587M |
| Gross Margin: | $317.6M |
| Return on Equity: | -87.53% |
| Return on Assets: | -31.86% |
Emergent BioSolutions Earnings Forecast
Key Emergent BioSolutions Financial Ratios
- The Gross Profit Margin over the past 22 years for EBS is 31.05%.
- The Selling, General & Administrative Expenses for EBS have been equal to 36.01% of Gross Profit Margin.
- The Research & Development expenses have been 10.89% of Revenue.
- The Interest Expense is -11.56% of Operating Income.
- The Net Earning history of EBS is -74.34% of Total Revenues.
- Per Share Earnings over the last 23 years have been positive in 12 years.
Emergent BioSolutions Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | EBS |
| CUSIP: | 29089Q |
| Website: | emergentbiosolutions.com |
Debt
| Debt-to-Equity Ratio: | 2.23 |
|---|---|
| Current Ratio: | 1.06 |
| Quick Ratio: | 0.43 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 3.06 |
EBS Technical Analysis vs Fundamental Analysis
Sell
40
Emergent BioSolutions (EBS)
is a Sell
Is Emergent BioSolutions a Buy or a Sell?
-
Emergent BioSolutions stock is rated a Sell
The current Emergent BioSolutions [EBS] share price is $9.12. The Score for EBS is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.